Low-grade systemic inflammation is one of the earliest and main pathological events that might lead to the development of insulin resistance in most insulin-sensitive tissues (Kloting and Bluher, 2014; Parimisetty et al., 2016). The gene discussed is INS; the disease is Insulin resistance.